Noor Ul Huda

Dr. Noor Ul Huda


Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2023 in Green Processing and Synthesis
Verified
Journal Article
Open access
PDF file
NHNoor Ul Huda
Noor Ul Huda
HGHazem Khader Ghneim
Hazem Khader Ghneim
FFFozia Fozia
Fozia Fozia
MAMushtaq Ahmed
Mushtaq Ahmed
NMNadia Mushtaq
Nadia Mushtaq
Mourad A. M. Aboul-SoudMourad A. M. Aboul-Soud
Mourad A. M. Aboul-Soud
The synthesis of silver nanoparticles (AgNPs) by the green method is favored as compared to chemical synthesis due to their appreciable properties of less toxicity and simple synthesis. The current study designed the biosynthesis of AgNPs in one step by using the plant Kickxia elatine (KE) extract and then investigated its inhibiting activity against rat’s brain acetylcholinesterase (AChE) ex vivo. Ultraviolet spectrum at 416 nm confirmed the formation of AgNPs. X-ray diffractometer calculated size was reported to be 42.47 nm. The SEM analysis confirmed spherical-shaped AgNPs. FT-IR suggested that the phytochemical groups present in the KE extract and their nanoparticles (NPs) are responsible for the biosynthesized of NPs. EDX analysis presented that Ag was the chief element with 61.67%. Both KE extract and AgNPs showed significant anti-AChE activity at 175 µg·mL −1 . Statistical analysis showed that both KE and AgNPs exhibited non-competitive type inhibition against AChE, i.e. V max decreased (34.17–68.64% and 22.29–62.10%), while K m values remained constant. It is concluded that KE and AgNPs can be considered an inhibitor of rats’ brain AChE. Furthermore, the synthesis of AgNP-based drugs can be used as a cheaper and alternative option against diseases such as Alzheimer’s disease.

12 March 2025 in Biological Trace Element Research
Verified
Journal Article
Closed access
PDF file
NANoshaba Afshin
Noshaba Afshin
NMNadia Mushtaq
Nadia Mushtaq
MAMushtaq Ahmed
Mushtaq Ahmed
SBSaboor Badshah
Saboor Badshah
SWSultan Mehmood Wazir
Sultan Mehmood Wazir
Hajra HameedHajra Hameed
Hajra Hameed

19 December 2025 in Molecular Biotechnology
Verified
Journal Article
Closed access
PDF file
NHNoor Ul Huda
Noor Ul Huda
PAProf. Dr. Mushtaq Ahmad
Prof. Dr. Mushtaq Ahmad
SBSaboor Badshah
Saboor Badshah
NMNadia Mushtaq
Nadia Mushtaq
RARahmat Alikhan
Rahmat Alikhan
FBFarhad Badshah
Farhad Badshah

12 November 2026 in Pathogens
Verified
Journal Article
Open access
PDF file
SKShahid Khan
Shahid Khan
MAMushtaq Ahmed
Mushtaq Ahmed
SQSania Subhan Qureshi
Sania Subhan Qureshi
FKFarhan Anwar Khan
Farhan Anwar Khan
NHNoor Ul Huda
Noor Ul Huda
ABDULKAREEM M MATARABDULKAREEM M MATAR
ABDULKAREEM M MATAR
Foot-and-mouth disease (FMD) is a highly contagious viral disease of cloven-hoofed animals. Continuous genetic variation in circulating field strains complicates vaccine matching and highlights the need for efficient virus isolation for vaccine seed production. Nineteen ELISA-confirmed FMDV serotype O field isolates from the Veterinary Research Institute (VRI), Peshawar, were sequentially cultured in ZZR-127 and BHK-21 cell lines. Each cell line underwent three serial passages. Antigen detection in culture supernatants (antigen-capture ELISA, positivity threshold OD ≥ 0.1, set empirically) and qualitative cytopathic effect (CPE) were used as indicators of virus recovery and propagation; infectious virus was not titrated. RT-PCR, performed on BHK-21 supernatants only, confirmed the presence of FMDV genomic material. Passage-dependent changes and predictors of adaptation success were analyzed using linear mixed-effects models, linear regression, and logistic regression. On ZZR-127 cells, antigen was detectable at passage 3 (P3; operationally defined here as “adaptation success”) in 12/19 isolates (63.2%). A non-significant positive trend in ELISA optical density (OD) values was observed across ZZR-127 passages (β = +0.123, p = 0.069); because the inoculum volume was doubled from 0.5 mL (P1) to 1.0 mL (P2–P3), this trend cannot be attributed to adaptation. In an exploratory logistic regression, initial OD was inversely associated with P3 positivity (β = −2.3769, p = 0.036), but the estimate was imprecise (OR = 0.093, 95% CI 0.009–0.956; 12 adapted vs. 7 non-adapted isolates) and sensitive to the omission of single isolates; this is a hypothesis-generating observation only. Antigen was detectable in all 12 isolates (100%) by P3 on BHK-21 cells, but in only 6/12 (50%) at P1 and 8/12 (66.7%) at P2; the 100% figure therefore depends on the arbitrary choice of P3 as the endpoint. A model-based decline in OD across BHK-21 passages (β = −0.171, p = 0.033) reflected the inclusion of the ZZR-127 P3 inoculum reading as “passage 0”; when restricted to BHK-21 readings (P1–P3), OD increased with passage (β = +0.317 per passage), so no conclusion on attenuation or antigen yield can be drawn. BHK-21 supernatants from all 12 isolates were RT-PCR positive for the FMDV VP1 region; ZZR-127 supernatants were not tested. The sequential use of ZZR-127 followed by BHK-21 cells was examined descriptively. Because no concurrent BHK-21-only control, mock-infected control, infectivity assay (TCID50/plaque assay) or sequencing was included, no conclusion can be drawn on efficiency relative to direct BHK-21 isolation, on viral replication or adaptation, or on vaccine seed potential, and comparison with published BHK-21 isolation rates is indicative only. These preliminary data are hypothesis-generating and require validation in controlled experiments, including cross-neutralization (r1 values), antigen stability and in vivo protection studies.